(ORTI-B) Ortivus ser. - Performance -50% in 12m
Compare ORTI-B with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-76.86%
#45 in Group
Rel. Strength
11.03%
#7147 in Universe
Total Return 12m
-49.99%
#35 in Group
Total Return 5y
-66.27%
#34 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -9.61%
19th Percentile in Group
12m Total Return: ORTI-B (-50%) vs XLV (0.3%)
5y Drawdown (Underwater) Chart
Top Performers in Life Sciences Tools & Services
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| A NYSE Agilent Technologies |
-11.6% | -21.5% | 44.2% | 23.5 | 18.4 | 1.68 | 58.4% | 7.8% |
| RVTY NYSE Revvity |
-12.1% | -7.4% | 7.42% | 39 | 18.2 | 0.64 | -63.9% | -30.6% |
| TECH NASDAQ Bio-Techne |
-16.2% | -19.5% | -1.48% | 51.8 | 22.6 | 1.07 | -31.9% | -5.85% |
| SHC NASDAQ Sotera Health |
-6.5% | -1.46% | -55.6% | 65.6 | 20.2 | 1.68 | -43.6% | - |
Performance Comparison: ORTI-B vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ORTI-B
| Total Return (including Dividends) | ORTI-B | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -25.70% | -4.97% | -4.31% |
| 3 Months | -23.52% | -6.08% | -7.85% |
| 12 Months | -49.99% | 0.26% | 10.76% |
| 5 Years | -66.27% | 47.01% | 106.31% |
| Trend Score (consistency of price movement) | ORTI-B | XLV | S&P 500 |
| 1 Month | -80.1% | -54.4% | -35.6% |
| 3 Months | -55.3% | -66.1% | -89.7% |
| 12 Months | -70.0% | -12% | 58.3% |
| 5 Years | -70.4% | 90% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #42 | -21.8% | -22.4% |
| 3 Month | #21 | -18.6% | -17.0% |
| 12 Month | #36 | -50.1% | -54.9% |
| 5 Years | #33 | -77.1% | -83.7% |
FAQs
Does ORTI-B Ortivus ser. outperforms the market?
No,
over the last 12 months ORTI-B made -49.99%, while its related Sector, the Health Care Sector SPDR (XLV) made 0.26%.
Over the last 3 months ORTI-B made -23.52%, while XLV made -6.08%.
Over the last 3 months ORTI-B made -23.52%, while XLV made -6.08%.
Performance Comparison ORTI-B vs Indeces and Sectors
ORTI-B vs. Indices ORTI-B is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -18.5% | -21.4% | -16.7% | -60.8% |
| US NASDAQ 100 | QQQ | -20.4% | -21.5% | -16.7% | -62.0% |
| US Dow Jones Industrial 30 | DIA | -16.4% | -19.9% | -16.9% | -57.0% |
| German DAX 40 | DAX | -15.8% | -21.9% | -35.1% | -73.5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -11.9% | -22.2% | -15.2% | -58.6% |
| Hongkong Hang Seng | HSI | -16.2% | -22.8% | -18.5% | -64.0% |
| India NIFTY 50 | INDA | -11.0% | -27.3% | -18.3% | -51.8% |
| Brasil Bovespa | EWZ | -18.2% | -27.7% | -21.2% | -44.5% |
ORTI-B vs. Sectors ORTI-B is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -18.3% | -20.1% | -25.4% | -72.4% |
| Consumer Discretionary | XLY | -20.8% | -21.7% | -19.8% | -64.3% |
| Consumer Staples | XLP | -11.0% | -28.5% | -22.0% | -59.5% |
| Energy | XLE | -15.1% | -14.1% | -14.2% | -38.1% |
| Financial | XLF | -16.5% | -20.9% | -24.8% | -69.3% |
| Health Care | XLV | -15.4% | -20.7% | -14.7% | -50.3% |
| Industrial | XLI | -16.6% | -21.6% | -17.0% | -56.9% |
| Materials | XLB | -15.2% | -21.2% | -9.77% | -44.7% |
| Real Estate | XLRE | -13.6% | -23.8% | -14.5% | -65.1% |
| Technology | XLK | -22.3% | -21.2% | -11.8% | -56.2% |
| Utilities | XLU | -14.3% | -27.4% | -19.8% | -70.4% |
| Aerospace & Defense | XAR | -18.0% | -25.4% | -27.9% | -77.0% |
| Biotech | XBI | -17.6% | -17.9% | -3.57% | -47.7% |
| Homebuilder | XHB | -16.7% | -19.7% | -1.68% | -42.0% |
| Retail | XRT | -15.7% | -22.8% | -12.5% | -46.4% |